Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer.
about
Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysisComparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis.Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.Nomogram to predict rectal toxicity following prostate cancer radiotherapy.Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysisRectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis.Hypofractionated radiotherapy for prostate cancer.Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer.Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002.Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimensBiological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.Optimal fractionation in radiotherapy with multiple normal tissues.First clinical implementation of the Capri applicator.Decreasing the Dose to the Rectal Wall by Using a Rectal Retractor during Radiotherapy of Prostate Cancer: A Comparative Treatment Planning Study
P2860
Q33613683-4CBF4B1B-A22B-4E87-86C5-9C5E282C6688Q33626084-2E615217-7974-458A-9D0A-BDA5A461E352Q34413524-271004F2-14A3-4386-9DCC-7A51C1DBEAECQ36412497-225A6C6A-F83F-436F-9FE4-BFD26A3143B4Q36680259-256077BD-030D-4D5F-82CF-3CB207E4CBEEQ37725623-EE98CB6F-16C0-4592-9EDA-1C0B7D805AA2Q38283897-D6B9E56F-F42B-450F-BF98-71463C4AAE82Q38603388-0A0C380A-C663-46C2-B53A-EFD3BF7681A3Q40959958-BDA68BD4-84CC-4BCF-93DB-83784D4B1BE6Q42139601-D5794316-CF14-4AD0-9AC2-9A0BD74F90CDQ50075623-4586BED8-01B2-4481-8F5F-D4C63991D5ADQ50912967-3DCC6066-AE57-46E8-9FE8-E00A78AEA116Q51123546-0B7A3E58-F67F-4DC1-9016-E5BB79C0C009Q59050740-CB25E0BA-68F0-465C-902D-441804DD3BEA
P2860
Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Modeling of alpha/beta for lat ...... for localized prostate cancer.
@en
Modeling of alpha/beta for lat ...... for localized prostate cancer.
@nl
type
label
Modeling of alpha/beta for lat ...... for localized prostate cancer.
@en
Modeling of alpha/beta for lat ...... for localized prostate cancer.
@nl
prefLabel
Modeling of alpha/beta for lat ...... for localized prostate cancer.
@en
Modeling of alpha/beta for lat ...... for localized prostate cancer.
@nl
P2093
P2860
P356
P1476
Modeling of alpha/beta for lat ...... for localized prostate cancer
@en
P2093
Biancamaria Saracino
Giorgio Arcangeli
Marcello Benassi
Maria G Petrongari
Sara Gomellini
Stefano Arcangeli
P2860
P2888
P356
10.1186/1756-9966-28-117
P577
2009-08-19T00:00:00Z
P5875
P6179
1030747314